Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Fuxing Chen

Biographic Data

ID10005910
NAMEFuxing Chen
GIVEN NAMESFuxing
FAMILY NAMEChen
SIGNATURECHEN F
AFFILIATIONSZhejiang Center for Disease Control and Prevention
ORCID0000-0001-7240-2699
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2025
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Factors associated with serious adverse event following immunization

    Open Access•Xuejiao Pan, Yaping Chen et al.•ARTICLE•Frontiers in Public Health•2026

    Background and aims: While vaccination is a vital and cost-effective public health tool, a small fraction of recipients experience serious adverse events (SAEs) that impose a profound clinical and systemic burden. Identifying the specific factors that predispose an individual to an SAE remains complex due to limitations in existing literature. This study analyzes SAE following immunization in the US population and identifies associated factors. M…

  • Cost-effectiveness analysis of herpes zoster vaccination for adults aged 50 years in Zhejiang province, China

    Open Access•Fuxing Chen, Linglin Ding et al.•ARTICLE•Frontiers in Public Health•2025

    Objective: Live-attenuated zoster vaccine (LZV) and adjuvanted recombinant zoster vaccine (RZV) have been approved for use in China. This study aimed to evaluate and compare the cost-effectiveness of these two herpes zoster (HZ) vaccination strategies in a birth cohort of individuals aged 50 years. Methods: The cost-effectiveness of RZV and LZV was compared to no vaccination strategy using a lifetime Markov model from a societal perspective. Mode…

No prominent works on this page.

  • Cost-effectiveness analysis of herpes zoster vaccination for adults aged 50 years in Zhejiang province, China

    Open Access•Fuxing Chen, Linglin Ding et al.•ARTICLE•Frontiers in Public Health•2025

    Objective: Live-attenuated zoster vaccine (LZV) and adjuvanted recombinant zoster vaccine (RZV) have been approved for use in China. This study aimed to evaluate and compare the cost-effectiveness of these two herpes zoster (HZ) vaccination strategies in a birth cohort of individuals aged 50 years. Methods: The cost-effectiveness of RZV and LZV was compared to no vaccination strategy using a lifetime Markov model from a societal perspective. Mode…

  • Factors associated with serious adverse event following immunization

    Open Access•Xuejiao Pan, Yaping Chen et al.•ARTICLE•Frontiers in Public Health•2026

    Background and aims: While vaccination is a vital and cost-effective public health tool, a small fraction of recipients experience serious adverse events (SAEs) that impose a profound clinical and systemic burden. Identifying the specific factors that predispose an individual to an SAE remains complex due to limitations in existing literature. This study analyzes SAE following immunization in the US population and identifies associated factors. M…

Vaccination (2 works) · Adverse effect (1 work) · Adverse Event Reporting System (1 work) · China (1 work) · Cytomegalovirus and herpesvirus research (1 work) · Facial Nerve Paralysis Treatment and Research (1 work) · Geography (1 work) · Herpesvirus Infections and Treatments (1 work) · Logistic regression (1 work) · Medical history (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae